Parabilis Medicines Prices Upsized IPO at $19 per Share
Parabilis Medicines priced its upsized initial public offering (IPO) of 33.3 million shares at $19 each, the top end of its marketed range, raising approximately $633.3 million in gross proceeds. The underwriters have a 30-day option to purchase an additional ~5 million shares.
Topics: biotech equity financing ipo